- Home
- VANI
as 03-28-2025 4:00pm EST
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. It develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division.
| Founded: | 1998 | Country: | United States |
| Employees: | N/A | City: | ALAMEDA |
| Market Cap: | 65.2M | IPO Year: | 2014 |
| Target Price: | $4.00 | AVG Volume (30 days): | 102.0K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.44 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.03 - $2.22 | Next Earning Date: | 05-12-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of Vivani Medical Inc. (DE) (VANI)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Dwyer Donald | VANI | Chief Business Officer | Feb 28 '25 | Buy | $1.11 | 1,000 | $1,110.00 | 51,000 |
Latest Vivani Medical Inc. (DE) News
VANI Breaking Stock News: Dive into VANI Ticker-Specific Updates for Smart Investing
GlobeNewswire
2 days ago
Vivani Medical Announces $8.25M Private Placement Equity Financing
Exec Edge
3 days ago
Vivani Medical Gives Data for Weight Loss Implant
GlobeNewswire
3 days ago
Vivani Medical Announces Positive Preclinical Weight Loss Data for NPM-139 Semaglutide Implant, with Potential for Once-Yearly Dosing
Benzinga
3 days ago
EXCLUSIVE: Vivani Medical Subdermal Semaglutide Implant Shows 20% Weight Loss In Animal Study, With Potential For Once-Yearly Dosing
GlobeNewswire
3 days ago
Presenting on the Emerging Growth Conference 80 Day 2 on March 27 Register Now
Business Wire
5 days ago
Vivani Medical to Present at the Emerging Growth Conference on March 27, 2025
Zacks
12 days ago
What Makes Vivani Medical (VANI) a New Buy Stock
Exec Edge
16 days ago
Vivani Medical Achieves 1st Implant & Full Enrollment in Overweight Trial
Compare VANI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "VANI Vivani Medical Inc. (DE) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.